Prevalence and factors associated with anxiety and depression amongst hospitalised COVID-19 patients in Laquintinie Hospital Douala, CameroonResearch Article Published on 2021-12-022022-10-28 Journal: PLoS ONE [Category] COVID-19, [키워드] African age Analysis Anxiety BMI carried collected data Comorbidity COVID-19 COVID-19 complication COVID-19 patient COVID-19 patients cross-sectional cut-off Depression disaster disease Factor Gender greater HADS hospital hospitalised COVID-19 patient hospitalised patient hypoxaemia incidence include Infection male mental health mental health problems multivariate logistic regression p value Panic Patient patients patients with COVID-19 Prevalence previous study Psychiatric recruited Region Sociodemographic characteristics statistical significance Stress Support was used with COVID-19 [DOI] 10.1371/journal.pone.0260819 PMC 바로가기 [Article Type] Research Article
Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trialCOVID-19 및 사이토카인 방출 증후군(COV-AID) 징후가 있는 환자에서 항인터루킨 약물의 효과: 요인, 무작위, 대조 시험Randomized Controlled Trial Published on 2021-12-012022-09-12 Journal: The Lancet. Respiratory Medicine [Category] Fulltext, SARS, 임상, 진단, [키워드] 95% CI assessment assigned baseline Belgium Block randomisation blockade C-reactive protein concentration center challenge Clinical improvement Complete Concentration Controlled trial COVID-19 Cytokine release syndrome D-dimer defined diagnosis of COVID-19 discharge drug Effect Efficacy Endpoint EudraCT evaluate Evidence factorial design failure ferritin fraction hazard ratio hospital hospitalised patient hypoxia hypoxic respiratory failure IL-1 IL-6 IL-6 blockade incidence intention-to-treat analysis intention-to-treat population interleukin International intravenously IQR lactate dehydrogenase less lymphopenia male mechanical ventilation median median age median time morbidity and mortality Mortality mortality risk Most patient multicentre Open-label oxygen PaO pathway Patient patients died patients with COVID-19 Primary outcome randomisation randomised Randomly receive Registered Safety safety population SARS-CoV-2 Serious Adverse Event serious infection serum single dose SOFA SOFA score Stratification study groups study outcome supplemental oxygen Symptom syndrome systemic cytokine therapeutic strategy Tocilizumab treatment group Trial were assessed with COVID-19 [DOI] 10.1016/S2213-2600(21)00377-5 PMC 바로가기 [Article Type] Randomized Controlled Trial
Soluble ST2 concentrations associate with in-hospital mortality and need for mechanical ventilation in unselected patients with COVID-19가용성 ST2 농도는 COVID-19로 선택되지 않은 환자의 병원 내 사망률 및 기계적 환기의 필요성과 관련이 있습니다.Observational Study Published on 2021-12-012022-09-11 Journal: Open Heart [Category] SARS, 바이오마커, 임상, [키워드] association baseline Biobank Biomarker Biomarkers cardiovascular disease Chronic kidney disease collected Comparisons Concentration COVID-19 demonstrated determine diabetes disease severity elevated Endothelial dysfunction enrolled fibrosis heart failure hospitalisation hospitalised patient Hospitalised patients hypertension hypoxaemia ICU ICU treatment In-hospital In-hospital death in-hospital mortality independent independent of Inflammation Inflammatory intensive care intensive care unit IQR Kidney disease lower oxygen saturation lung Lungs Male sex mechanical ventilation median Myocardial myocardial fibrosis non-survivor Non-survivors Older age outcome outcomes oxygen pathophysiological pathophysiology patients died patients with COVID-19 produced reflect registration number respiratory rate Risk factors robust SARS-CoV-2 smoking ST2 survivor thrombosis Treatment Viraemia with COVID-19 [DOI] 10.1136/openhrt-2021-001884 PMC 바로가기 [Article Type] Observational Study
Prevention and management of thrombosis in hospitalised patients with COVID-19 pneumoniaReview article Published on 2021-11-252022-10-05 Journal: The Lancet. Respiratory Medicine [Category] COVID19(2023년), SARS, 임상, [키워드] acute-phase response Antithrombotic approach benefit Clinical findings Coagulation Coagulopathy contribute COVID-19 develop Disseminated intravascular coagulation Endothelial dysfunction Health highlight hospital discharge hospitalised patient implication increased risk infected with SARS-CoV-2 Inflammatory response key consideration Laboratory laboratory feature management moderate outcomes pathophysiology patients with COVID-19 Pneumonia prevention Prophylaxis proportion question SARS-COV-2 infection severe COVID-19 Support therapeutic anticoagulation thromboembolic complications Thromboprophylaxis thrombosis Treatment Trial understanding with COVID-19 [DOI] 10.1016/S2213-2600(21)00455-0 [Article Type] Review article
Ten months of temporal variation in the clinical journey of hospitalised patients with COVID-19: An observational cohortResearch Article Published on 2021-11-232022-10-31 Journal: eLife [Category] COVID-19, MERS, SARS, [키워드] Admission Analysis Care case fatality ratio clinician Cohort Commonwealth COVID-19 development discharge disease severity Epidemic Foreign foundation had no HDU high dependency unit hospital Hospital admission Hospital stay hospitalisation hospitalised hospitalised patient Human ICU improvement Infectious disease intensive care International limitation lowest manuscript Melinda Gate office outcome measure pandemic Patient Probability provided resource SARS-CoV-2 Study design supported Survivors symptom onset time trials variable Variation viruses with COVID-19 [DOI] 10.7554/eLife.70970 PMC 바로가기 [Article Type] Research Article
Analysis of the diagnostic accuracy of rapid antigenic tests for detection of SARS-CoV-2 in hospital outbreak situationOriginal Article Published on 2021-11-182022-10-31 Journal: European Journal of Clinical Microbiology & Infect [Category] COVID-19, [키워드] Abbott Accuracy analysed antigen detection asymptomatic screening calculated COVID-19 COVID-19 test COVID-19 testing cross-sectional defined diagnostic Diagnostic method epidemiologically hospital Hospital wards hospitalised patient Negative predictive value negative RT-PCR Non-COVID-19 NPV outbreak Outbreaks Patient performed polymerase chain positive Positive predictive value positive RT-PCR PPV Ramón Rapid antigen tests rapid antigenic test RT-PCR SARS-CoV-2 Screening sensitivity specificity study period TaqPath transcriptase was performed [DOI] 10.1007/s10096-021-04346-8 PMC 바로가기 [Article Type] Original Article
NK and T Cell Immunological Signatures in Hospitalized Patients with COVID-19COVID-19로 입원한 환자의 NK 및 T 세포 면역학적 특징Article Published on 2021-11-152022-09-11 Journal: Cells [Category] MERS, SARS, 치료기술, 치료제, [키워드] Activation acute respiratory syndrome analysed caused CD16 CD25 CD56 CD69 China Clinical severity Concentration control groups coronavirus coronavirus 2 correlation COVID-19 COVID-19 infection COVID-19 patient cytokine cytokine release Cytokines cytomegalovirus died Direct enrolled flow cytometry Frequency healthy subject hospitalised patient human population IL-6 immune response immunology increase in inhibitory involved lung transplant maintain Mild moderate modulate Multiplex assay NK cell NK cells NKG2A overexpression Patient patients with COVID-19 PD-1 phenotype progression reported respiratory SARS-COV-2 infection serum serum cytokines Severe acute respiratory syndrome severe COVID-19 patients severe disease signature significantly higher Stimulation stratified subset Survivors T cell T cell subset T cells T-cell responses targeted therapy Viral viral infections with COVID-19 Wuhan [DOI] 10.3390/cells10113182 PMC 바로가기 [Article Type] Article
Can treatment with teicoplanin improve the prognosis of COVID-19 patients?Clinical Trial Published on 2021-11-012022-10-05 Journal: International journal of clinical practice [Category] SARS, 임상, [키워드] addition administration Adverse reaction Arm baseline characteristics Can clinical investigation Clinical outcome Comorbidity comparable control arm control group COVID-19 COVID-19 patients effect of treatment hospitalised patient IMPROVE laboratory-confirmed lower mortality mortality rate mortality rate; no significant difference organization outcome Patient patients with COVID-19 presenting symptoms Prognosis reported required Retrospective study significantly significantly lower standard care Teicoplanin teicoplanin. treated Treatment two groups with COVID-19 [DOI] 10.1111/ijcp.14752 PMC 바로가기 [Article Type] Clinical Trial
The Impact of COVID-19 on Levels of Adherence to the Completion of Nursing Records for Inpatients in IsolationObservational Study Published on 2021-10-272022-10-04 Journal: International Journal of Environmental Research an [Category] MERS, SARS, 임상, [키워드] adhere adherence changes completion COVID-19 COVID-19 pandemic decrease First wave hospital hospitalised hospitalised patient Impact Inpatient Isolation Level Nurse Nurses Nursing nursing care nursing records observational studies pandemic Patient Patient Isolation phase pressure ulcers Record Research risk significantly STROBE took place with COVID-19 [DOI] 10.3390/ijerph182111262 PMC 바로가기 [Article Type] Observational Study
Nafamostat in hospitalized patients with moderate to severe COVID-19 pneumonia: a randomised Phase II clinical trialResearch article Published on 2021-10-272022-10-05 Journal: EClinicalMedicine [Category] 신약개발, 임상, [키워드] 28-day mortality 95% CI age baseline Bioscience Biotechnology CKD Clinical improvement clinical trial Controlled trial Coronavirus disease 2019 (COVID-19) COVID-19 COVID-19 patient Day death Disseminated intravascular coagulation Efficacy enrolled evaluated finding funding group groups high-flow oxygen therapy hospitalised patient hospitalized patient IQR mechanical ventilation median median time moderate multicentre nafamostat Nafamostat mesilate nasal no significant difference Non-invasive Open-label Oxygen treatment Patient patients phase Pneumonia primary endpoint Primary outcome randomised randomized clinical trial Rate Ratio receiving Registered Russia score secondary outcome serine protease inhibitor Serious Adverse Event severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) severe COVID-19 significantly higher Standard-of-care the patient Time to recovery Treatment Trial was recorded with COVID-19 [DOI] 10.1016/j.eclinm.2021.101169 [Article Type] Research article